These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29221882)

  • 1. Effective inhibition of Cbf-14 against Cryptococcus neoformans infection in mice and its related anti-inflammatory activity.
    Yu C; Wei S; Han X; Liu H; Wang M; Jiang M; Guo M; Dou J; Zhou C; Ma L
    Fungal Genet Biol; 2018 Jan; 110():38-47. PubMed ID: 29221882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
    Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
    Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brilacidin, a novel antifungal agent against
    Diehl C; Pinzan CF; de Castro PA; Delbaje E; García Carnero LC; Sánchez-León E; Bhalla K; Kronstad JW; Kim D-g; Doering TL; Alkhazraji S; Mishra NN; Ibrahim AS; Yoshimura M; Vega Isuhuaylas LA; Pham LTK; Yashiroda Y; Boone C; Dos Reis TF; Goldman GH
    mBio; 2024 Jul; 15(7):e0103124. PubMed ID: 38916308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
    Vu K; Gelli A
    Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An active domain SA-2 derived from cystatin-SA, and its antifungal activity.
    Liu X; Huang X; Wang J; Zhang M; Liu M; Zhou C; Ma L
    Amino Acids; 2023 Jan; 55(1):101-112. PubMed ID: 36333524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Najvar LK; Bocanegra R; Caselli F; Di Cesare S; Giannini D; Di Francesco LF; Giacometti A; Carle F; Scalise G; Graybill JR
    Antimicrob Agents Chemother; 2001 May; 45(5):1355-9. PubMed ID: 11302795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
    J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the
    Tancer RJ; Wang Y; Pawar S; Xue C; Wiedman GR
    Microbiol Spectr; 2022 Apr; 10(2):e0043922. PubMed ID: 35377230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.
    Treviño-Rangel Rde J; Villanueva-Lozano H; Hernández-Rodríguez P; Martínez-Reséndez MF; García-Juárez J; Rodríguez-Rocha H; González GM
    Med Mycol; 2016 Mar; 54(3):280-6. PubMed ID: 26705833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antifungal activity of cinnamaldehyde against Cryptococcus neoformans var. grubii.
    Neelabh ; Singh K
    Folia Microbiol (Praha); 2020 Dec; 65(6):973-987. PubMed ID: 32617865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.
    Sanguinetti M; Posteraro B; La Sorda M; Torelli R; Fiori B; Santangelo R; Delogu G; Fadda G
    Infect Immun; 2006 Feb; 74(2):1352-9. PubMed ID: 16428784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide as a novel anticryptococcal agent.
    Cenci E; Bistoni F; Mencacci A; Perito S; Magliani W; Conti S; Polonelli L; Vecchiarelli A
    Cell Microbiol; 2004 Oct; 6(10):953-61. PubMed ID: 15339270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of
    Yang L; Tian Z; Zhou L; Zhu L; Sun C; Huang M; Peng J; Guo G
    Infect Drug Resist; 2022; 15():233-248. PubMed ID: 35115792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antimicrobial Peptide MK58911-NH
    Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria.
    Ma L; Wang Y; Wang M; Tian Y; Kang W; Liu H; Wang H; Dou J; Zhou C
    Biomaterials; 2016 May; 87():32-45. PubMed ID: 26897538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection.
    Nosanchuk JD; Ovalle R; Casadevall A
    J Infect Dis; 2001 Apr; 183(7):1093-9. PubMed ID: 11237835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans.
    Yang L; Tian Z; Zhao W; Zhang J; Tian C; Zhou L; Jiao Z; Peng J; Guo G
    Bioorg Chem; 2023 Sep; 138():106679. PubMed ID: 37329812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tipranavir exhibits different effects on opportunistic pathogenic fungi.
    Cenci E; Francisci D; Belfiori B; Pierucci S; Baldelli F; Bistoni F; Vecchiarelli A
    J Infect; 2008 Jan; 56(1):58-64. PubMed ID: 17905438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo synergistic effects of hydroxychloroquine and itraconazole on Cryptococcus neoformans.
    Wang X; Long X; Jia S; Zhu J; Zhou Z; Ahmed S; Jiang Y; Jiang Y
    Folia Microbiol (Praha); 2023 Aug; 68(4):595-605. PubMed ID: 36753031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the anticryptococcal activity of the antibiotic polymyxin B in vitro and in vivo.
    Zhai B; Lin X
    Int J Antimicrob Agents; 2013 Mar; 41(3):250-4. PubMed ID: 23313397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.